Alignment healthcare director Konowiecki sells $400k in stock

Published 01/08/2025, 23:22
Alignment healthcare director Konowiecki sells $400k in stock

Director Joseph S. Konowiecki of Alignment Healthcare, Inc. (NASDAQ:ALHC) sold 25,000 shares of common stock on July 31, 2025, at a price of $16.0, for a total transaction value of $400,000. The transaction comes as ALHC shares have shown strong momentum, with InvestingPro data showing a 50% return over the past year. The company, currently valued at $2.56 billion, maintains a GOOD financial health score according to InvestingPro’s comprehensive analysis.

Following the transaction, Konowiecki directly owns 1,152,049 shares of Alignment Healthcare. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025. InvestingPro analysis reveals the company trades at premium multiples, with additional insights available in the comprehensive Pro Research Report, which covers what really matters for informed investment decisions.

In other recent news, Alignment Healthcare reported impressive second-quarter 2025 earnings, with earnings per share (EPS) reaching $0.07, a significant improvement from the projected -$0.07. The company’s revenue also surpassed expectations, hitting $1 billion compared to the forecasted $960.51 million. This strong performance highlights the company’s robust business growth. Barclays (LON:BARC) responded to these results by upgrading Alignment Healthcare’s stock rating from Underweight to Equalweight. The firm also raised its price target for the company from $9.00 to $13.00. Barclays noted that the earnings report exceeded expectations, with revenue coming in 6% above forecasts and EBITDA $32 million higher than anticipated for core operations. Additionally, membership growth was reported to be 1% above projections. These developments reflect a positive outlook for Alignment Healthcare, as indicated by the analyst upgrade.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.